Capital Flow Monitor · Sponsors · CIK 1929085
Enumera Molecular, Inc.
600 S. WAGNER RD., ANN ARBOR, MI, 48103 · 650-308-8544
Other Health Care · Corporation· inc. DELAWARE true 2022
Fit score
—
Offering
$17.4M
Sold
$12.3M
% sold
70.9%
Investors
12
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-07-31 | D ·current | 506(b) | $17.4M | $12.3M | 70.9% | 12 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
-
Matthew Cooper — Executive Officer / Director, Ann Arbor, MI
5 other raises
- Polis Strategies Fund LLC - Series 5 $1.9M of $1.9M · 100.0%
- Allotera Therapeutics, Inc. $123.3M of $163.0M · 75.6%
- Polis Strategies Fund LLC - Series 1 $1.9M of $1.9M · 100.0%
- Polis MedTech Ventures LLC - Series 4 $900K of $900K · 100.0%
- Polis MedTech Ventures LLC - Series 3 $2.5M of $2.5M · 100.0%
- Dan Kidle — Director, Ann Arbor, MI
-
Elaine Heron — Director, Ann Arbor, MI
1 other raise
- BlueWhale Bio, Inc. $5.0M of $15.0M · 33.3%
- Sundaresh Brahmasandra — Director, Ann Arbor, MI
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.